Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 01, 2024

Camostat vs Placebo for the Treatment of Painful Chronic Pancreatitis



Additional Info

Disclosure statements are available on the authors' profiles:

A Randomized Controlled Phase 2 Dose-Finding Trial to Evaluate the Efficacy and Safety of Camostat in the Treatment of Painful Chronic Pancreatitis: The TACTIC Study
Gastroenterology 2023 Dec 14;.(.)., PA Hart, Y Osypchuk, I Hovbakh, RJ Shah, J Nieto, GA Cote, S Avgaitis, O Kremzer, J Buxbaum, S Inamdar, R Fass, RW Phillips, D Yadav, AM Ladd, MT Al-Assi, T Gardner, DL Conwell, S Irani, A Sheikh, J Nuttall

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading